MNHRX | RGWBX | MNHRX / RGWBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 13 years | - |
Gain YTD | 1.675 | 2.506 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250 | 800% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 474M | 21B | 2% |
Annual Yield % from dividends | 0.52 | 0.08 | 655% |
Returns for 1 year | 8.01 | 16.86 | 48% |
Returns for 3 years | -4.51 | 4.57 | -99% |
Returns for 5 years | 7.49 | 29.12 | 26% |
Returns for 10 years | 11.55 | 69.87 | 17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FLRAX | 41.06 | 0.38 | +0.93% |
Nuveen Large Cap Select A | |||
PAITX | 19.83 | 0.07 | +0.35% |
T. Rowe Price International Stock Adv | |||
MNDKX | 32.15 | 0.08 | +0.25% |
MFS New Discovery R6 | |||
ICEWX | 37.81 | 0.03 | +0.08% |
NYLI Epoch International Choice Class C | |||
FBTDX | 106.93 | -0.13 | -0.12% |
Franklin Biotechnology Discovery C |